Published in Eur Heart J on May 24, 2007
Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol (2009) 2.58
Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol (2010) 1.18
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J (2005) 6.86
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med (2003) 2.92
Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. J Am Coll Cardiol (2012) 2.38
Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol (2007) 2.22
Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation (2003) 1.91
Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J (2011) 1.82
Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med (2005) 1.74
The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol (2009) 1.66
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol (2006) 1.65
Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging (2009) 1.61
Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans. Circulation (2004) 1.59
Absolute quantification of myocardial blood flow with H(2)(15)O and 3-dimensional PET: an experimental validation. J Nucl Med (2002) 1.57
Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis (2006) 1.49
Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol (2007) 1.47
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: Implications for pharmacologic stress testing in coronary artery disease. J Nucl Cardiol (2006) 1.39
Patent foramen ovale closure and brain ischaemic lesions. Heart (2013) 1.39
Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation (2002) 1.36
Coronary microvascular dysfunction: an update. Eur Heart J (2013) 1.28
Program of cell survival underlying human and experimental hibernating myocardium. Circ Res (2004) 1.27
Coronary microvascular resistance: methods for its quantification in humans. Basic Res Cardiol (2009) 1.26
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J (2009) 1.26
Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging (2010) 1.19
Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol (2006) 1.13
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J (2009) 1.12
Respiratory gating of cardiac PET data in list-mode acquisition. Eur J Nucl Med Mol Imaging (2006) 1.10
Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J (2007) 1.09
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J (2012) 1.08
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 1.07
Can silent brain lesions be a target to guide anticoagulation treatment in patients with low-risk atrial fibrillation to reduce cognitive impairment? J Am Coll Cardiol (2014) 1.06
Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol (2010) 1.05
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol (2011) 1.03
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes (2002) 1.00
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging (2013) 0.97
Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy. J Cardiovasc Transl Res (2009) 0.95
Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation (2004) 0.93
[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC]. Kardiol Pol (2005) 0.93
Assessment of myocardial ischaemia and viability: role of positron emission tomography. Eur Heart J (2010) 0.91
Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. J Am Coll Cardiol (2002) 0.91
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med (2008) 0.91
Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation. J Nucl Med (2006) 0.91
Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol (2002) 0.90
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. Eur J Nucl Med Mol Imaging (2004) 0.90
Myocardial beta-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure. Eur Heart J (2010) 0.90
Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT. J Nucl Med (2010) 0.90
123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials. J Nucl Cardiol (2009) 0.89
Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol (2002) 0.89
Is there evidence supporting coronary revascularization in patients with left ventricular systolic dysfunction? Circ J (2010) 0.88
Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance. J Nucl Med (2002) 0.87
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab (2002) 0.86
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. Int J Cardiol (2008) 0.86
Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart. Eur J Nucl Med Mol Imaging (2007) 0.85
Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. J Hypertens (2011) 0.84
Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med (2005) 0.84
Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol (1985) (2008) 0.83
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Res Cardiol (2002) 0.83
Pre- and post-synaptic sympathetic function in human hibernating myocardium. Eur J Nucl Med Mol Imaging (2007) 0.83
A novel (18)F-labeled tracer for the quantification of myocardial blood flow and infarct size with positron-emission tomography: another way to avoid the need of an on-site cyclotron. Circ Cardiovasc Imaging (2009) 0.82
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction. Eur J Nucl Med Mol Imaging (2002) 0.82
Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences. Ital Heart J (2004) 0.82
Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat. Basic Res Cardiol (2012) 0.82
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging (2004) 0.82
Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study. J Renin Angiotensin Aldosterone Syst (2003) 0.81
Is central nervous system processing altered in patients with heart failure? Eur Heart J (2004) 0.81
Hypertrophic cardiomyopathy: The need for randomized trials. Glob Cardiol Sci Pract (2013) 0.80
[Guidelines on the management of stable angina pectoris. Executive summary]. Rev Esp Cardiol (2006) 0.80
Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy. J Heart Lung Transplant (2004) 0.79
Methods to investigate coronary microvascular function in clinical practice. J Cardiovasc Med (Hagerstown) (2013) 0.79
Myocardial stunning is associated with impaired calcium uptake by sarcoplasmic reticulum. Biochem Biophys Res Commun (2009) 0.78
Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging (2002) 0.78
Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses. Am J Physiol Heart Circ Physiol (2007) 0.78
Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography. Eur J Nucl Med Mol Imaging (2006) 0.78
Cardiac nociception. Circulation (2006) 0.78
[Guidelines for percutaneous coronary interventions]. Rev Esp Cardiol (2005) 0.77
Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol (2009) 0.77
The blunting of coronary flow reserve in hypertension with left ventricular hypertrophy is transmural and correlates with systolic blood pressure. J Hypertens (2014) 0.77
Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction. Basic Res Cardiol (2002) 0.77
[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]. Kardiol Pol (2006) 0.77
[Guidelines for percutaneous coronary interventions]. Ital Heart J Suppl (2005) 0.77
Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the persantine in stable angina (PISA) study. J Cardiovasc Pharmacol (2006) 0.77
Absolute figures are better than percentages. JACC Cardiovasc Imaging (2009) 0.77
Quantification of [11C]GB67 binding to cardiac alpha1-adrenoceptors with positron emission tomography: validation in pigs. Eur J Nucl Med Mol Imaging (2008) 0.77
[Cardiac involvement at rest in patients with systemic sclerosis: differences between the limited and the diffuse form of the disease]. G Ital Cardiol (Rome) (2014) 0.76
Myocardial viability in ischemic left ventricular dysfunction. N Engl J Med (2011) 0.76
Need for new non-invasive imaging strategies to identify high-risk asymptomatic patients with carotid stenosis. Int J Cardiol (2013) 0.76
From Left Ventricular Hypertrophy to Dysfunction and Failure. Circ J (2016) 0.76
Positron emission tomography for quantitation of myocardial perfusion. J Nucl Cardiol (2004) 0.76
Coronary microvascular dysfunction in patients with cardiomyopathies. Circ Heart Fail (2008) 0.76
Molecular imaging of vascular inflammation. Eur J Nucl Med Mol Imaging (2010) 0.75
Risk stratification of patients with normal myocardial perfusion imaging: help comes from the periphery. Eur Heart J (2013) 0.75
Myocardial ischaemia and metabolic memory. Eur J Nucl Med Mol Imaging (2006) 0.75
A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial. J Am Coll Cardiol (2011) 0.75
["African sickness" and the heart: the mystery of endomyocardial fibrosis]. G Ital Cardiol (Rome) (2011) 0.75
An accordion not to be played. J Cardiovasc Med (Hagerstown) (2017) 0.75
[Guidelines on the management of stable angina pectoris: executive summary]. G Ital Cardiol (Rome) (2006) 0.75
[Stunning, hibernation, and heart failure in patients with coronary disease: crucial role of impaired coronary flow reserve]. Ital Heart J Suppl (2003) 0.75
Hibernation and congestive heart failure. Heart Fail Rev (2003) 0.75
Calcified left ventricular endomyocardial fibrosis. J Heart Valve Dis (2012) 0.75
[Revascularization of the hibernated myocardium: a clinical problem still unsolved]. G Ital Cardiol (Rome) (2012) 0.75